Association of Lower Extremity Vascular Disease, Coronary Artery, and Carotid Artery Atherosclerosis in Patients with Type 2 Diabetes Mellitus

The motive of this article is to present the case study of patients to investigate the association between the ultrasonographic findings of lower extremity vascular disease (LEAD) and plaque formation. Secondly, to examine the association between the formation of coronary artery and carotid artery atherosclerosis in patients with type 2 diabetes mellitus. 124 patients with type 2 diabetes (64 males and 60 females with the age group 25-78 years) are considered for the research studies who have registered themselves in the Department of Endocrinology and Metabolism from April 2017 to February 2019. All participants have reported their clinical information regarding diabetes, alcohol consumption, smoking status, and medication. The blood samples from subjects are collected for measurement of HbA1c, total cholesterol, triglycerides, HDL-c, and LDL-c levels. Two-dimensional ultrasound has been used to measure the inner diameter, peak flow velocity, blood flow, and spectral width of the femoral artery, pop artery, anterior iliac artery, posterior tibial artery, and dorsal artery and to calculate the artery stenosis degree. Independent factors of atherosclerosis are determined by multivariate logistic regression analysis. The results are evaluated within the control group and it is found that there is no significant impact of gender, age, and body mass index (P > 0.05) on the lower extremity vascular diseases. Those with smoking, alcohol consumption, hypertension, and dyslipidemia have higher positive rate (P < 0.05). The type 2 diabetes mellitus group has higher diastolic blood pressure and lower triglyceride (P < 0.05). Diastolic blood pressure, HbA1C, total cholesterol, HDL-c, and LDL-C are not remarkably dissimilar between the type 2 diabetes mellitus group and the control group (P > 0.05). Compared with the control group, the type 2 diabetes mellitus group has higher frequency of lower extremity vascular diseases in the dorsal artery than in the pop artery (P < 0.05). The blood flow of type 2 diabetes mellitus group is found to be lower than that of the control group, especially in the dorsal artery (P < 0.05). The blood flow velocity of the dorsal artery is accelerated (P < 0.01). Among 117 patients of type 2 diabetes mellitus (94.35%) with a certain degree of injury, there are 72 cases of type I carotid stenosis (58.06%), 30 cases of type II carotid stenosis (24.19%), and 15 cases of type III carotid stenosis (12.10%). Out of 108 subjects in the control group, there are 84 cases of type 0 carotid stenosis (77.78%), 19 cases of type I carotid stenosis (17.59%), 5 cases of type II carotid stenosis (4.63%), and 0 case of type III carotid stenosis (0.00%). Compared with the control group, carotid stenosis is more common in patients with type 2 diabetes mellitus (P < 0.05). Age, smoking, duration of diseases, systolic blood pressure, and degree of carotid stenosis are found to be associated with atherosclerosis. The findings suggest that the color Doppler ultrasonography can give early warning when applied in patients with carotid and lower extremity vascular diseases to delay the incidence of diabetic macroangiopathy and to control the development of cerebral infarction, thus providing an important basis for clinical diagnosis and treatment.

[1]  Vishal Jagota,et al.  RETRACTED ARTICLE: Research on optimization of scientific research performance management based on BP neural network , 2021, International Journal of System Assurance Engineering and Management.

[2]  Mohammad Shabaz,et al.  Predicting future diseases based on existing health status using link prediction , 2021 .

[3]  Dipti D. Patil,et al.  A comprehensive survey on investigation techniques of exhaled breath (EB) for diagnosis of diseases in human body , 2021 .

[4]  V. Aboyans,et al.  Lower extremity artery disease in patients with type 2 diabetes , 2019, European journal of preventive cardiology.

[5]  M. Clements,et al.  Assessment of biomarkers of inflammation and premature atherosclerosis in adolescents with type-1 diabetes mellitus , 2019, Journal of pediatric endocrinology & metabolism : JPEM.

[6]  L. Roever,et al.  High-Intensity Interval Training in Patients with Type 2 Diabetes Mellitus: a Systematic Review , 2019, Current Atherosclerosis Reports.

[7]  K. Hansson,et al.  Radiographic and ultrasonographic findings in a dog with emphysematous pyometra , 2018, Acta Veterinaria Scandinavica.

[8]  V. Rigalleau,et al.  Lower extremity arterial disease in patients with diabetes: a contemporary narrative review , 2018, Cardiovascular Diabetology.

[9]  Jian-fei Song,et al.  Triglyceride-mediated influence of serum angiopoietin-like protein 8 on subclinical atherosclerosis in type 2 diabetic patients: results from the GDMD study in China , 2018, Cardiovascular Diabetology.

[10]  K. Sung,et al.  Association of baseline level of physical activity and its temporal changes with incident hypertension and diabetes mellitus , 2018, European journal of preventive cardiology.

[11]  R. Kronmal,et al.  Incidence and predictors of clinical peripheral artery disease in asymptomatic persons with a low ankle–brachial index , 2018, Journal of medical screening.

[12]  J. Ijzermans,et al.  Contribution of Type 2 Diabetes Mellitus to Subclinical Atherosclerosis in Subjects with Morbid Obesity , 2018, Obesity Surgery.

[13]  A. Atta,et al.  Association of CXCL13 serum level and ultrasonographic findings of joints in patients with systemic lupus erythematosus and Jaccoud’s arthropathy , 2018, Lupus.

[14]  S. Jee,et al.  ApoB/ApoA-I ratio is independently associated with carotid atherosclerosis in type 2 diabetes mellitus with well-controlled LDL cholesterol levels , 2017, The Korean journal of internal medicine.

[15]  C. Alpers,et al.  A Novel Type 2 Diabetes Mouse Model of Combined Diabetic Kidney Disease and Atherosclerosis. , 2017, The American journal of pathology.

[16]  Seung Min Chung,et al.  Serum cystatin C is associated with subclinical atherosclerosis in patients with type 2 diabetes: A retrospective study , 2018, Diabetes & vascular disease research.

[17]  A. Iagnocco,et al.  Definition and Reliability Assessment of Elementary Ultrasonographic Findings in Calcium Pyrophosphate Deposition Disease: A Study by the OMERACT Calcium Pyrophosphate Deposition Disease Ultrasound Subtask Force , 2017, The Journal of Rheumatology.

[18]  N. Nakamura,et al.  Relationship between limited joint mobility of hand and carotid atherosclerosis in patients with type 2 diabetes. , 2017, Diabetes research and clinical practice.

[19]  I. Shimomura,et al.  Dose-Dependent Effect of Sitagliptin on Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Post Hoc Analysis , 2017, Diabetes Therapy.

[20]  J. Pankow,et al.  Experiences of Discrimination and Incident Type 2 Diabetes Mellitus: The Multi-Ethnic Study of Atherosclerosis (MESA) , 2017, American journal of epidemiology.

[21]  B. Merkely,et al.  Signs of subclinical atherosclerosis in asymptomatic patients at increased risk of type 2 diabetes mellitus. , 2017, Journal of diabetes and its complications.

[22]  S. Ramachandran,et al.  T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders , 2017, Scientific Reports.

[23]  D. Mauricio,et al.  Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes , 2017, Cardiovascular Diabetology.

[24]  Zubang Zhou,et al.  The Association Between Endocan Levels and Subclinical Atherosclerosis in Patients With Type 2 Diabetes Mellitus , 2017, The American journal of the medical sciences.

[25]  N. Wyre,et al.  Radiographic and ultrasonographic findings of the spleen and abdominal lymph nodes in healthy domestic ferrets , 2017, The Journal of small animal practice.

[26]  M. Borowska,et al.  Homocysteine as a non-classical risk factor for atherosclerosis in relation to pharmacotherapy of type 2 diabetes mellitus. , 2017, Acta biochimica Polonica.

[27]  K. Suzuma,et al.  Correlation of retinal arterial wall thickness with atherosclerosis predictors in type 2 diabetes without clinical retinopathy , 2016, British Journal of Ophthalmology.

[28]  E. Armstrong,et al.  Peripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomes. , 2015, World journal of diabetes.

[29]  J. Mukai,et al.  LOX-1 is a novel marker for peripheral artery disease in patients with type 2 diabetes. , 2013, Metabolism: clinical and experimental.